| Prefecture |
Organization |
Institute Director |
Introduction of your Technology, Product and Study |
Technology Classification/Product Classification |
Contact |
| Enterprise |
Kringle Pharma, Inc.
|
Kunio Iwatani
|
Kringle Pharma was founded as a spin-off biotech company out of Osaka University. Its target is to provide a solution for unmet medical needs through research and clinical development of hepatocyte growth factor, HGF. Kringle has established a manufacturing system of GMP-compliant recombinant human HGF, and is now conducting clinical trials of HGF domestically and overseas. Kringle is seeking to conclude strategic alliance (co-R&D, licensing, etc.) with major pharmaceutical companies. |
[Technology Classification]
-BB14/Life Innovation/Regenerative Medicine/Kidney
-BB12/Life Innovation/Regenerative Medicine/Neuron
-BB06/Life Innovation/Regenerative Medicine/Skin
[Product Classification]
-BA02/Life Innovation/Drug Discovery & Diagnosis/Therapeutic Agent
|
+81-6-6831-3330
info@kringle-pharma.com |
| Enterprise |
PHG Corporation
|
Yoshiaki Furutani
|
[Artifiical Collagen]Artificial Collagen is a polypeptide having characteristics similar to native collagen which features a triple-helical structure, and is chemically synthesized based on genomic information. Because this artificial collagen does not use raw material of the animal origin and has an extremely low possibility of pathogen infection, PHG focuses on the development of biomaterial utilizing artificial collagen. |
[Technology Classification]
-BB01/Life Innovation/Regenerative Medicine/ Scaffold & Biomaterial
-BB06/Life Innovation/Regenerative Medicine/Skin
-BB12/Life Innovation/Regenerative Medicine/Neuron
[Product Classification]
-BB04/Life Innovation/Medical Equipment/Medical Supplies
|
+81-75-325-6055
info@phg.co.jp |
| Enterprise |
TOYOKAGAKU CORPORATION
|
Department of Research & Development
Koichi Oka (Representative Chief Director)
|
Our company produces first aid bandages and blood clotting tapes, etc. Specifically, silicone adhesive tapes have been used as first aid bandages for more than ten years by only our company. Recently we developed a wound dressing for wet healing. One is a natural polysaccharide gel dressing and the other type is a hydrocolloid type made with our own technology. As we can supply any company for sale as your brand, feel free to call OEM production. Now we are keen on wider application technology developing such DDS, or TDS for collaboration with the user's pharmaceutical agent. |
[Technology Classification]
-BB06/Life Innovation/Regenerative Medicine/Skin
-BA09/Life Innovation/Drug Discovery & Diagnosis/DDS
[Product Classification]
-BB04/Life Innovation/Medical Equipment/Medical Supplies
-BA02/Life Innovation/Drug Discovery & Diagnosis/Therapeutic Agent
|
+81-77-559-2102
|
| University |
Kwansei Gakuin University
|
School of Science and Technology, Department of Bioscience
Yohei Hirai
|
Our bodies consist of as many as 60 trillion cells, in which the cells are regularly collocated and organically composed to build up various body parts such as tissues and organs. These function units mutually tie in and play respective roles to contribute to higher life phenomena. In order to use the newly created ES cells and iPS cells with versatility in differentiation for regenerative medicine, it is necessary to establish technology for enabling and regulating differentiation and tissues-construction. In our laboratory, we have proceeded research on the molecular basis for cell differentiation, tissue-construction, and the regulation mechanism using various human undifferentiated normal cells and mice as models. We have discovered regulation proteins for tissue-construction and have chemically synthesized the agonists and antagonists thereto. Their medical application is now under investigation. |
[Technology Classification]
-A006/Basic Technology/Basic & Fundamental Technology/Cultivation, Differentiation & Separation of Cell & Tissue
-BB03/Life Innovation/Regenerative Medicine/Evaluation
-BB06/Life Innovation/Regenerative Medicine/Skin
|
+81-79-565-9052
ip.renkei@kwansei.ac.jp |
